10 Stocks on Jim Cramer’s Radar

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 92

A caller asked if Pfizer Inc. (NYSE:PFE) was a buy or not and Cramer remarked:

“Well, let me tell you something… right now, we have a government that is trying to figure out whether it’s going to tax the heck out of drug companies, raise tariffs outta drug companies or not. I can’t make a prediction anymore. It yields 8%. Normally I say fine, but you know what? Let’s say you decide, you know what, we need big tariffs on Pfizer. You’ll say, wow, I’m buying that stock at 18 rather than 21. So I’m going to have to say, pass.”

Pfizer Inc. (NYSE:PFE) focuses on discovering, creating, manufacturing, and supplying biopharmaceutical products. Its work covers areas such as heart health, infectious illness, cancer treatment, immune system conditions, and vaccines. On March 31, Cramer said:

“Is Pfizer dead money? I mean I think it’s been mummified. I don’t know. I mean it’s like, wow. Look at that thing. Close the casket… Alright, Pfizer is unfortunately dead money. Dr. Bourla’s a terrific guy… what can I say? He’s a terrific guy. He’s a terrific guy.”

While we acknowledge the potential of Pfizer Inc. (NYSE:PFE) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.